TFF2 and clear cell adenocarcinoma: A combination of HIK1083 and TFF2 testing can be useful, as TFF2 is expressed in 80% of gastric-type tumors compared with 12% of non–gastric-type tumors, with no clear cell carcinomas having been shown to be positive.